The New York Entrepreneur

[stock-market-ticker symbols="AAPL;MSFT;GOOG;HPQ;^SPX;^DJI;LSE:BAG" stockExchange="NYSENasdaq" width="100%" palette="financial-dark"]

Menu

Home
Wall Street Today
Economy
- Market Analysis
Newsletters and Research
Cryptocurrency
Business
Finance
Market Analysis
Money

Home
2024
October
Sage Therapeutics’ stock slides after Alzheimer’s Disease trial fails to meet main goal

Sage Therapeutics’ stock slides after Alzheimer’s Disease trial fails to meet main goal

October 8, 2024

Share

Read Time:0 Second

Post Content

About Post Author

Happy

0 0 %

Sad

0 0 %

Excited

0 0 %

Sleepy

0 0 %

Angry

0 0 %

Surprise

0 0 %

0

0

Average Rating

5 Star

0%

4 Star

0%

3 Star

0%

2 Star

0%

1 Star

0%

(Add your review)

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Comment *

Rating* 5 4 3 2 1 0

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.

Type in the text displayed above

Previous post PepsiCo trims revenue outlook as North American snacking, key international markets lag

Next post After 70, is Social Security enough money to live on — or should I buy an annuity?

More Stories

WeightWatchers’ stock soars after adding compounded GLP-1 to offering

Post Content

October 8, 2024

Scholar Rock’s stock soars more than 200% on positive trial of treatment for spinal muscular atrophy

Post Content

October 7, 2024

Chevron Canada to sell assets to Canadian Natural Resources for $6.5 billion in cash

Post Content

October 7, 2024

Barnes’ stock jumps 2.7% after company agrees to be acquired by Apollo for $3.6 billion in cash

Post Content

October 7, 2024

Silver miner SilverCrest’s stock surges after Coeur Mining’s $1.7 billion buyout bid

Post Content

October 4, 2024

Rivian’s stock dives after production disruption leads to a deliveries guidance cut

Post Content

October 4, 2024

Post navigation

Previous post:PepsiCo trims revenue outlook as North American snacking, key international markets lag

Next post:After 70, is Social Security enough money to live on — or should I buy an annuity?

Search for:

Recent Posts

‘It’s just almost impossible to do it all’: Here’s how much time and money the sandwich generation is spending on eldercare
Microsoft’s stock heads for a ‘death cross’ — but there are bigger chart problems
Hurricane Milton drives gas demand in Florida, with 16% of stations out of fuel
Big beer brands’ struggles seem likely to continue into next year, analyst says
Slotmaker Aristocrat works to protect its IP while moving to a digital future

Wall Street Today

Wall Street Today

Stocks to Watch

Other

Newsletters & Research

Policy & Regulation

Business

© 2022 The New York Entrepreneur. All Rights Reserved.